# RIXUBIS Drug Use-Result Survey (Japan)

> **NCT02937831** · — · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 6 (actual)

## Conditions studied

- Hemophilia B

## Interventions

- **BIOLOGICAL:** RIXUBIS

## Key facts

- **NCT ID:** NCT02937831
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-16
- **Primary completion:** 2022-05-11
- **Final completion:** 2022-05-11
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02937831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02937831, "RIXUBIS Drug Use-Result Survey (Japan)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02937831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*